Search
for
Sort by
Research 61–90 of 350
- From bedside to bench: regulation of host factors in SARS-CoV-2 infection
- The effect of low-level laser therapy on severe acute respiratory syndrome coronavirus-2 infected cells
- TMPRSS2: A Key Host Factor in SARS-CoV-2 Infection and Potential Therapeutic Target
- Sex differences in COVID-19: the role of androgens in disease severity and progression
- Androgen deprivation therapy may constitute a more effective COVID-19 prophylactic than therapeutic strategy
- Evaluating cepharanthine analogues as natural drugs against SARS‐CoV‐2
- ENZYMES
- Anticoronavirus Isoquinoline Alkaloids: Unraveling the Secrets of Their Structure–Activity Relationship
- An update of anti-viral treatment of COVID-19
- The brief overview, antivirus and anti-SARS-CoV-2 activity, quantitative methods, and pharmacokinetics of cepharanthine: a potential small-molecule drug against COVID-19
- Genetic Variants and Protective Immunity against SARS-CoV-2
- Two years of SARS-CoV-2 infection (2019–2021): structural biology, vaccination, and current global situation
- Network-based identification genetic effect of SARS-CoV-2 infections to Idiopathic pulmonary fibrosis (IPF) patients
- Extrapulmonary manifestations of coronavirus disease (COVID-19): current status (a literature review)
- Lupeol: an updated review utilizing AI-assisted predictive tools for enhanced therapeutic insights into lupeol’s potential for alopecia management
- Hair loss after SARS-CoV2 Infection
- COVID-19: Pulmonary and Extra Pulmonary Manifestations
- Antiviral and Anti-Inflammatory Plant-Derived Bioactive Compounds and Their Potential Use in the Treatment of COVID-19-Related Pathologies
- Systematic characterization of the barrier function of diverse ex vivo models of damaged human skin
- Bioactivity and In Silico Studies of Isoquinoline and Related Alkaloids as Promising Antiviral Agents: An Insight
- Antiandrogens as Therapies for COVID-19: A Systematic Review
- SARS-CoV-2 Infection and Alpha-Synucleinopathies: Potential Links and Underlying Mechanisms
- What’s Sex Got to Do With COVID-19? Gender-Based Differences in the Host Immune Response to Coronaviruses
- A review on computer‐aided chemogenomics and drug repositioning for rationalCOVID‐19 drug discovery
- The impact of SARS-CoV-2 and COVID-19 on male reproduction and men’s health
- Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening Methods
- Characterization of Clinical Features of Hospitalized Patients Due to the SARS-CoV-2 Infection in the Absence of Comorbidities Regarding the Sex: An Epidemiological Study of the First Year of the Pandemic in Brazil
- Unraveling the mechanism of action of cepharanthine for the treatment of novel coronavirus pneumonia (COVID-19) from the perspectives of systematic pharmacology
- Cepharanthine Dry Powder Inhaler for the Treatment of Acute Lung Injury
- Exosomes in stroke management: A promising paradigm shift in stroke therapy